Viking Therapeutics, Inc.
VKTX
$24.99
-$0.67-2.61%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/25/2025
-
MarketBeat
4/26/2025
-
MarketBeat
4/25/2025
-
TipRanks Financial Blog
4/25/2025
-
The Fly
4/25/2025
-
24/7 Wall St.
4/25/2025
-
MarketBeat
4/25/2025
-
Investing.com-Stock Analysis
4/25/2025
-
MarketBeat
4/25/2025
-
MarketBeat
4/25/2025
-
MarketBeat
4/24/2025
-
MarketBeat
4/24/2025
-
MarketBeat
4/24/2025
-
Simply Wall St
4/24/2025
-
Zacks Investment Research
4/24/2025
-
GuruFocus
4/24/2025
-
The Fly
4/24/2025
-
SeekingAlpha
4/24/2025
-
TipRanks Financial Blog
4/24/2025
-
Zacks Investment Research
4/24/2025
-
GuruFocus
4/24/2025
-
GuruFocus
4/24/2025
-
GuruFocus
4/24/2025
-
Insider Monkey
4/24/2025
-
GuruFocus
4/16/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, April 24, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Jul 21 and 25 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 704 4660
Address
9920 Pacific Heights Boulevard
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is...
more